January 2019
Medicare Part B medical specialty drug prior authorization lists changing in 2019
Some updates are coming for the Part B medical specialty medical prior authorization drug list for Blue Cross Medicare Plus BlueSM PPO and BCN AdvantageSM members. These changes include additions and removals from the prior authorization program as follows.
Medicare Plus Blue PPO
Removals — for dates of service starting Jan. 1, 2019:
- J0202 Lemtrada®
- J2323 Tysabri®
- J2350 Ocrevus®
Additions — for dates of service starting Feb. 1, 2019:
- C9036 Onpattro™
- J2840 Kanuma®
- J2860 Sylvant®
- J3357 Stelara® SQ
- J3358 Stelara® IV
- J1746 Trogarzo™
- J9022 Tecentriq®
- J9023 Bavencio®
- J9042 Adcetris®
- J9176 Empliciti®
- J9308 Cyramza®
- J9352 Yondelis®
For Medicare Plus Blue, we require prior authorization for these medications when you bill them on a professional CMS-1500 claim form or by electronic submission via an 837P transaction, for the following sites of care:
- Physician office (place of service code 11)
- Outpatient facility (place of service code 19, 22 or 24)
We don’t require authorization for these medications when you bill them on a facility claim form (such as a UB04) or electronically via an 837I transaction.
BCN Advantage
Removals — for dates of service starting Jan. 1, 2019:
- J9032 Beleodaq®
- J9310 Rituxan®
Additions — for dates of service starting Feb. 1, 2019:
- J2860 Sylvant®
- J3357 Stelara® SQ
- J3358 Stelara® IV
- J3490/C9399 Onpattro™
- J1746 Trogarzo™
- J9022 Tecentriq®
- J9023 Bavencio®
- J9042 Adcetris®
- J9176 Empliciti®
- J9352 Yondelis®
For BCN Advantage, we require prior authorization for these medications when you bill them on a professional CMS-1500 claim form (or submit them electronically via an 837P transaction) or on a facility claim form such as a UB04 (or submit them electronically via an 837I transaction), for the following sites of care:
- Physician office (place of service code 11)
- Outpatient facility (place of service code 19, 22 or 24)
- Home (place of service code 12)
Reminder: You must get authorization prior to administering these medications. Use the NovoLogix® online tool to quickly submit your requests.
|